These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15463829)

  • 21. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.
    Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C
    J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Strausbaugh SD; Woo MS; Tong SY; Silber SA; Mulberg AE; Leitz G
    J Cyst Fibros; 2011 Sep; 10(5):350-6. PubMed ID: 21632288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dependence of PERT endpoint on endogenous lipase activity.
    Gao WY; Mulberg AE
    Pancreas; 2014 Nov; 43(8):1232-8. PubMed ID: 25102439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of Creon® micro in children with exocrine pancreatic insufficiency due to cystic fibrosis.
    Kashirskaya NY; Kapranov NI; Sander-Struckmeier S; Kovalev V
    J Cyst Fibros; 2015 Mar; 14(2):275-81. PubMed ID: 25066363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
    Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
    Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
    J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
    J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
    Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
    Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V
    Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
    Regele S; Henker J; Münch R; Barbier Y; Stern M
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enzyme levels in blood are not affected by oral administration of a pancreatic enzyme preparation (Creon 10,000) in pancreas-insufficient pigs.
    Gewert K; Holowachuk SA; Rippe C; Gregory PC; Erlanson-Albertsson C; Olivecrona G; Kruszewska D; Piedra JV; Weström B; Pierzynowski SG
    Pancreas; 2004 Jan; 28(1):80-8. PubMed ID: 14707735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
    Woestenenk JW; van der Ent CK; Houwen RH
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
    Lancellotti L; Cabrini G; Zanolla L; Mastella G
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):73-8. PubMed ID: 8788291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres.
    Meyer JH; Lake R
    Pancreas; 1997 Oct; 15(3):226-35. PubMed ID: 9336785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency.
    Caras S; Boyd D; Zipfel L; Sander-Struckmeier S
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):634-40. PubMed ID: 21681115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.